160 related articles for article (PubMed ID: 32060788)
1. Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology.
Abuhussein O; Yang J
Invest New Drugs; 2020 Oct; 38(5):1316-1325. PubMed ID: 32060788
[TBL] [Abstract][Full Text] [Related]
2. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Martin JL; Julovi SM; Lin MZ; de Silva HC; Boyle FM; Baxter RC
Breast Cancer Res; 2017 Aug; 19(1):90. PubMed ID: 28778177
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.
Ling B; Chen L; Alcorn J; Ma B; Yang J
Invest New Drugs; 2011 Apr; 29(2):396-9. PubMed ID: 20041340
[TBL] [Abstract][Full Text] [Related]
5. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
6. Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR
Xiao S; Yang J
Invest New Drugs; 2019 Feb; 37(1):57-64. PubMed ID: 29860604
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effect between Sphingosine-1-Phosphate and Chemotherapy Drugs against Human Brain-metastasized Breast Cancer MDA-MB-361 cells.
Sultan A; Ling B; Zhang H; Ma B; Michel D; Alcorn J; Yang J
J Cancer; 2013; 4(4):315-9. PubMed ID: 23569464
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
Wang W; Hind T; Lam BWS; Herr DR
FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.
Liu CY; Su JC; Huang TT; Chu PY; Huang CT; Wang WL; Lee CH; Lau KY; Tsai WC; Yang HP; Shiau CW; Tseng LM; Chen KF
Mol Oncol; 2017 Mar; 11(3):266-279. PubMed ID: 28084011
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.
Matula K; Collie-Duguid E; Murray G; Parikh K; Grabsch H; Tan P; Lalwani S; Garau R; Ong Y; Bain G; Smith AD; Urquhart G; Bielawski J; Finnegan M; Petty R
BMC Cancer; 2015 Oct; 15():762. PubMed ID: 26493335
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S
Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
14. Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway.
Zhao P; Ma W; Hu Z; Zang L; Tian Z; Zhang K
Tumour Biol; 2016 Apr; 37(4):5107-15. PubMed ID: 26546439
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
Maia AR; de Man J; Boon U; Janssen A; Song JY; Omerzu M; Sterrenburg JG; Prinsen MB; Willemsen-Seegers N; de Roos JA; van Doornmalen AM; Uitdehaag JC; Kops GJ; Jonkers J; Buijsman RC; Zaman GJ; Medema RH
Ann Oncol; 2015 Oct; 26(10):2180-92. PubMed ID: 26153498
[TBL] [Abstract][Full Text] [Related]
16. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line.
Nøhr-Nielsen A; Bagger SO; Brünner N; Stenvang J; Lund TM
Eur J Pharm Sci; 2020 May; 148():105315. PubMed ID: 32201343
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.
Patmanathan SN; Johnson SP; Lai SL; Panja Bernam S; Lopes V; Wei W; Ibrahim MH; Torta F; Narayanaswamy P; Wenk MR; Herr DR; Murray PG; Yap LF; Paterson IC
Sci Rep; 2016 May; 6():25650. PubMed ID: 27160553
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.
Nagahashi M; Yamada A; Miyazaki H; Allegood JC; Tsuchida J; Aoyagi T; Huang WC; Terracina KP; Adams BJ; Rashid OM; Milstien S; Wakai T; Spiegel S; Takabe K
J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):9-17. PubMed ID: 27194029
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells.
Torki S; Soltani A; Shirzad H; Esmaeil N; Ghatrehsamani M
Biomed Pharmacother; 2017 Aug; 92():39-45. PubMed ID: 28528184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
